XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 88,109 $ 102,855
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 9,698 8,440
Stock-based compensation expense 5,536 5,247
Inventory impairments and abandonments 200 616
Deferred and other income tax expense 10,373 15,466
(Gain) loss on disposal of fixed assets (350) 1,178
Gain on sale of investment (8,591) 0
Loss on extinguishment of debt, net 437 533
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (18,968) 2,695
(Increase) decrease in income tax receivable (1,675) 9,987
Increase in inventory (412,665) (1,228)
Increase in other assets (1,374) (5,346)
Increase (decrease) in trade accounts payable 34,616 (6,828)
Decrease in other liabilities (28,327) (37,783)
Net cash (used in) provided by operating activities (322,981) 95,832
Cash flows from investing activities:    
Capital expenditures (16,691) (14,122)
Proceeds from sale of fixed assets 352 143
Purchases of investment securities (7,536) (7,838)
Other 0 (2)
Net cash used in investing activities (23,875) (21,819)
Cash flows from financing activities:    
Repayment of debt (202,195) (4,998)
Proceeds from issuance of debt 250,000 0
Repayment of borrowings from credit facility (150,000) 0
Borrowings from credit facility 195,000 0
Debt issuance costs (5,653) (2,575)
Repurchase of common stock (12,928) 0
Tax payments for stock-based compensation awards (5,237) (2,615)
Stock option exercises 16 12
Net cash provided by (used in) financing activities 69,003 (10,176)
Net (decrease) increase in cash, cash equivalents, and restricted cash (277,853) 63,837
Cash, cash equivalents, and restricted cash at beginning of period 386,289 251,828
Cash, cash equivalents, and restricted cash at end of period $ 108,436 $ 315,665